Citi Sees Limited Sales For Blood-Clot Drug At The Medicines Company By: Benzinga via Benzinga April 16, 2015 at 16:35 PM EDT The Medicines Company (NASDAQ: MDCO)'s blood-clot prevention drug will serve as a last-line treatment with limited sales, an analyst ... Read More >> Related Stocks: Medicines Company